Steven Williamson
Chief Executive Officer presso PULMONX CORPORATION
Patrimonio netto: 1 M $ in data 29/02/2024
Profilo
Steven S.
Williamson is a businessperson who has been at the head of 5 different companies.
He is President, Chief Executive Officer & Director at Pulmonx Corp., Co-Managing Director at Angiomed GmbH & Co. Medizintechnik KG and President for Bard Peripheral Vascular, Inc.
In the past Mr. Williamson was President-Peripheral Intervention at Becton, Dickinson & Co. Chief Executive Officer of FlowCardia, Inc. President & Director at SenoRx, Inc. and President-Peripheral Vascular at C.
R.
Bard, Inc. (New Jersey) (which are all subsidiaries of Becton, Dickinson & Co.), Senior Vice President & General Manager at Hologic, Inc. Territory Manager at CYTYC Surgical Products and Vice President-Sales & Marketing of Cytyc Corp.
(both are subsidiaries of Hologic, Inc.) and Chief Commercial Officer of Outset Medical, Inc.
He received an MBA from Bentley University and an undergraduate degree from the University of Massachusetts.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
OUTSET MEDICAL, INC.
0.63% | 15/02/2024 | 320 347 ( 0.63% ) | 1 M $ | 29/02/2024 |
Posizioni attive di Steven Williamson
Società | Posizione | Inizio |
---|---|---|
PULMONX CORPORATION | Chief Executive Officer | 15/03/2024 |
Bard Peripheral Vascular, Inc.
Bard Peripheral Vascular, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Bard Peripheral Vascular, Inc. provides surgical and interventional devices for peripheral vascular patency. The private company is based in Tempe, AZ. | President | 20/11/2012 |
Angiomed GmbH & Co. Medizintechnik KG
Angiomed GmbH & Co. Medizintechnik KG Aerospace & DefenseElectronic Technology Angiomed GmbH & Co. Medizintechnik KG manufactures electrical measuring, control and navigation instruments. The company is headquartered in Karlsruhe, Germany. | Chief Executive Officer | - |
Precedenti posizioni note di Steven Williamson
Società | Posizione | Fine |
---|---|---|
OUTSET MEDICAL, INC. | Corporate Officer/Principal | 01/03/2024 |
BECTON, DICKINSON AND COMPANY | Corporate Officer/Principal | 01/11/2020 |
C.R. BARD | Corporate Officer/Principal | 01/12/2017 |
HOLOGIC, INC. | Corporate Officer/Principal | 01/08/2012 |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Sales & Marketing | 22/10/2007 |
Formazione di Steven Williamson
Bentley University | Masters Business Admin |
University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
BECTON, DICKINSON AND COMPANY | Health Technology |
HOLOGIC, INC. | Health Technology |
PULMONX CORPORATION | Health Technology |
OUTSET MEDICAL, INC. | Health Technology |
Aziende private | 7 |
---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
CYTYC Surgical Products
CYTYC Surgical Products Pharmaceuticals: MajorHealth Technology CYTYC Surgical Products was founded to design, develop, manufacture and market innovative therapeutic devices that improve the quality of women's healthcare in a cost- effective manner. Its initial product, the Novasure Endometrial Ablation System, is used to treat women who suffer from excessive menstrual bleeding. | Health Technology |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Health Technology |
FlowCardia, Inc.
FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Health Technology |
Bard Peripheral Vascular, Inc.
Bard Peripheral Vascular, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Bard Peripheral Vascular, Inc. provides surgical and interventional devices for peripheral vascular patency. The private company is based in Tempe, AZ. | Health Technology |
Angiomed GmbH & Co. Medizintechnik KG
Angiomed GmbH & Co. Medizintechnik KG Aerospace & DefenseElectronic Technology Angiomed GmbH & Co. Medizintechnik KG manufactures electrical measuring, control and navigation instruments. The company is headquartered in Karlsruhe, Germany. | Electronic Technology |